These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8869768)

  • 1. Post-marketing cohort study comparing the safety and efficacy of flunarizine and propranolol in the prophylaxis of migraine.
    Verspeelt J; De Locht P; Amery WK
    Cephalalgia; 1996 Aug; 16(5):328-36; discussion 288. PubMed ID: 8869768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmarketing study of the use of flunarizine in vestibular vertigo and in migraine.
    Verspeelt J; De Locht P; Amery WK
    Eur J Clin Pharmacol; 1996; 51(1):15-22. PubMed ID: 8880046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the efficacy and safety of flunarizine to propranolol in the prophylaxis of migraine.
    Gawel MJ; Kreeft J; Nelson RF; Simard D; Arnott WS
    Can J Neurol Sci; 1992 Aug; 19(3):340-5. PubMed ID: 1393843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The treatment of juvenile migraine using flunarizine or propranolol].
    Lütschg J; Vassella F
    Schweiz Med Wochenschr; 1990 Nov; 120(46):1731-6. PubMed ID: 2251492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flunarizine vs. propranolol in the prophylaxis of migraine: two double-blind comparative studies in more than 400 patients.
    Lücking CH; Oestreich W; Schmidt R; Soyka D
    Cephalalgia; 1988; 8 Suppl 8():21-6. PubMed ID: 3180198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A postmarketing study of flunarizine in migraine and vertigo.
    de Bock GH; Eelhart J; van Marwijk HW; Tromp TP; Springer MP
    Pharm World Sci; 1997 Dec; 19(6):269-74. PubMed ID: 9443168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative trial of flunarizine and propranolol in the prevention of migraine.
    Shimell CJ; Fritz VU; Levien SL
    S Afr Med J; 1990 Jan; 77(2):75-7. PubMed ID: 2404346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flunarizine and propranolol in the treatment of migraine.
    Ludin HP
    Headache; 1989 Apr; 29(4):219-24. PubMed ID: 2654068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Paediatric migraine disability assessment score is a useful tool for evaluating prophylactic migraine treatment.
    Topcu Y; Hiz Kurul S; Bayram E; Sozmen K; Yis U
    Acta Paediatr; 2014 Nov; 103(11):e484-9. PubMed ID: 25048365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flunarizine in migraine prophylaxis: the clinical experience.
    Schmidt R; Oestreich W
    J Cardiovasc Pharmacol; 1991; 18 Suppl 8():S21-6. PubMed ID: 1726732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flunarizine in migraine prophylaxis: predictive factors for a positive response.
    Lucetti C; Nuti A; Pavese N; Gambaccini G; Rossi G; Bonuccelli U
    Cephalalgia; 1998; 18(6):349-52. PubMed ID: 9731940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of flunarizine in childhood migraine: 11 years' experience, with emphasis on its effect in hemiplegic migraine.
    Peer Mohamed B; Goadsby PJ; Prabhakar P
    Dev Med Child Neurol; 2012 Mar; 54(3):274-7. PubMed ID: 22268377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of migraine prophylaxis with flunarizine and beta-blockers.
    Wöber C; Wöber-Bingöl C; Koch G; Wessely P
    Cephalalgia; 1991 Dec; 11(6):251-6. PubMed ID: 1790569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flunarizine for prophylactic treatment of childhood migraine.
    Visudtibhan A; Lusawat A; Chiemchanya S; Visudhiphan P
    J Med Assoc Thai; 2004 Dec; 87(12):1466-70. PubMed ID: 15822542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up after flunarizine or nimodipine discontinuation in migraine patients.
    Nuti A; Lucetti C; Pavese N; Dell'Agnello G; Rossi G; Bonuccelli U
    Cephalalgia; 1996 Aug; 16(5):337-40. PubMed ID: 8869769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily.
    Diener HC; Matias-Guiu J; Hartung E; Pfaffenrath V; Ludin HP; Nappi G; De Beukelaar F
    Cephalalgia; 2002 Apr; 22(3):209-21. PubMed ID: 12047461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of flunarizine in the prophylaxis of migraine: a meta-analytical review of the literature].
    Reveiz-Herault L; Cardona AF; Ospina EG; Carrillo P
    Rev Neurol; 2003 May 16-31; 36(10):907-12. PubMed ID: 12766861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of migraine therapy: predictive value of the frontotemporal nitroglycerin test.
    Bonuso S; Di Stasio E; Marano E; de Angelis S; Amato D; Scellini T; Caruso G
    Neurology; 1998 Nov; 51(5):1475-8. PubMed ID: 9818888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The place of calcium antagonists in the prophylactic treatment of migraine.
    Ludin HP
    J Cardiovasc Pharmacol; 1991; 18 Suppl 8():S17-9. PubMed ID: 1726731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of amitriptyline and flunarizine on weight gain and serum leptin, C peptide and insulin levels when used as migraine preventive treatment.
    Berilgen MS; Bulut S; Gonen M; Tekatas A; Dag E; Mungen B
    Cephalalgia; 2005 Nov; 25(11):1048-53. PubMed ID: 16232156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.